Key Highlights
- Palmetto Pharm selects Inovalon’s ScriptMed® Specialty as their pharmacy management software, aiming to revolutionize patient care and administrative efficiency.
- Focus on Enhanced Collaboration: ScriptMed Specialty to facilitate improved collaboration among patients, providers, and health plans, speeding up therapies for better clinical and financial outcomes.
- Nationwide Expansion Goals: Palmetto Pharm leverages ScriptMed Specialty for its nationwide expansion and compliance with URAC and ACHC Specialty Pharmacy Accreditation.
Source: Direct
Notable Quotes
- “ScriptMed Specialty software met both our clinical and operational needs and gives us the technological harness to provide value to our customers with an end-to-end solution,” – Ryan Fennick, Founder and CEO at Palmetto Pharm
- “We designed ScriptMed to be an end-to-end, flexible cloud platform that grows with organizations like Palmetto Pharm as they scale to drive workflow efficiencies, personalize care plans, and make data actionable at all points of care for the best outcomes,” – Ernie Shopes, President and General Manager at Inovalon’s Pharmacy Business Unit
SoH's Take
The partnership between Inovalon and Palmetto Pharm marks a significant stride in the evolution of specialty pharmacy management. Inovalon’s ScriptMed® Specialty stands out as a pivotal tool, not just for its technological innovation, but for its role in shaping a more efficient, patient-centered healthcare landscape. This collaboration underlines a growing trend in the healthcare industry: the adoption of cloud-based, data-driven solutions to enhance operational efficiency and patient care. Palmetto Pharm’s commitment to a customer-centric approach, combined with Inovalon’s sophisticated platform, sets a new standard in pharmacy management, indicating a promising future for both patient outcomes and pharmacy operations. This move is especially crucial for start-ups like Palmetto Pharm, aiming to establish a strong foothold in the competitive specialty pharmacy market.
